Trials / Completed
CompletedNCT00851019
Dance Dance Revolution (DDR) in Type 2 Diabetes
Dance Dance Revolution (DDR) Exergaming in Adults With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 76 (actual)
- Sponsor
- Charles Drew University of Medicine and Science · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Regular physical activity is important for the treatment of type 2 diabetes, but it is often not sustained for many reasons, including lack of interest. New video games that involve physical movement ("exergames") may help in this regard. This study will compare the "exergame" "Dance Dance Revolution" (DDR) with traditional treadmill exercise on blood sugar control among sedentary, overweight or obese adults with type 2 diabetes.
Detailed description
This study is a randomized, controlled trial of a 3-month ad libitum program of the "exergame" "Dance Dance Revolution" (DDR) versus traditional treadmill exercise. Each group of subjects will be assessed at baseline, and then assigned exclusively to one of the two exercise modalities. Subjects will be free to attend exercise sessions in their assigned exercise modality at the exercise facility, at a frequency, duration and intensity of their own choosing with minimal staff supervision, for a period of exactly 90 days; adoption of new exercise programs outside of the study will be prohibited. Dosages of any concurrent medications will be maintained constant, and all subjects will receive standardized nutrition counseling.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | DDR | Ad libitum attendance to engage in "Dance Dance Revolution" (DDR) Exergaming, for a 3-month period |
| BEHAVIORAL | Treadmill | Ad libitum attendance to engage in treadmill exercise, for a 3-month period |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2009-02-25
- Last updated
- 2013-03-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00851019. Inclusion in this directory is not an endorsement.